PriceTargets.com logo

VIVO Cannabis - VVCIF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.02 As of 04/4/2023 09:59 PM ET
▲ +0.0007 (4.79%)

This chart shows the closing price for VVCIF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New VIVO Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VVCIF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VVCIF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for VIVO Cannabis in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.02.

This chart shows the closing price for VVCIF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in VIVO Cannabis. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/17/2020Clarus SecuritiesReiterated RatingBuy$0.70
6/24/2020Clarus SecuritiesReiterated RatingBuy$0.70
4/2/2020Clarus SecuritiesReiterated RatingBuy$0.70
1/21/2020Clarus SecuritiesReiterated RatingBuy$0.70
(Data available from 4/24/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
VIVO Cannabis logo
VIVO Cannabis, Inc. engages in the production and sale of cannabis-based products. It operates through the following segments: Cannabis Sales, Patient Clinics, and Corporate. The Cannabis Sales segment produces and sells cannabis and cannabis-derived products for direct sale to medical patients and for the adult-use market. The Patient Clinics segment operates a portfolio of education focused, patient-centric, and cannabis discovery clinics under the name of Harvest Medicine. The Corporate segment relates to the non-production related corporate activities and international operations. The company was founded by Ken Clement on April 12, 2007 and is headquartered in Napanee, Canada.
Read More

Today's Range

Now: $0.02
Low: $0.01
High: $0.02

50 Day Range

MA: $0.02
Low: $0.02
High: $0.02

52 Week Range

Now: $0.02
Low: $0.01
High: $0.07

Volume

1,600 shs

Average Volume

32,621 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of VIVO Cannabis?

The following Wall Street sell-side analysts have issued research reports on VIVO Cannabis in the last twelve months:
View the latest analyst ratings for VVCIF.

What is the current price target for VIVO Cannabis?

0 Wall Street analysts have set twelve-month price targets for VIVO Cannabis in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for VIVO Cannabis in the next year.
View the latest price targets for VVCIF.

What is the current consensus analyst rating for VIVO Cannabis?

VIVO Cannabis currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for VVCIF.

What other companies compete with VIVO Cannabis?

Other companies that are similar to VIVO Cannabis include 1933 Industries, 4Cable TV International, 4Front Ventures, AB Science and Abacus Health Products. Learn More about companies similar to VIVO Cannabis.

How do I contact VIVO Cannabis' investor relations team?

VIVO Cannabis' physical mailing address is 126 Vanluven Road, Napanee, ON K7R. The company's listed phone number is (416) 848-9839. The official website for VIVO Cannabis is vivocannabis.com. Learn More about contacing VIVO Cannabis investor relations.